CathRx sells first product to Europe
Wednesday, 17 September, 2008
CathRx [ASX: CXD] has secured the first sales of its diagnostic modular heart catheters to its UK distributor, in the company's first ever sale to Europe.
Cardiac catheters are minimally invasive tools widely used by specialist cardiologists to help diagnose and treat different types of cardiac arrhythmias.
The global market for cardiac catheters is predicted to be around $1.25 billion, with the European market alone worth $333.2 million.
CathRx plans to offer a progressively-expanding 'toolbox' of heart surgery tools to the European market in the next three quarters.
Breakthrough drug prevents long COVID symptoms in mice
Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction...
Antibiotics hinder vaccine response in infants
Infants who received antibiotics in the first few weeks of life had significantly lower levels of...
Colossal announces 'de-extinction' of the dire wolf
Colossal Biosciences has announced what it describes as the rebirth of the dire wolf, which would...